Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride
Owen L Woodman,1 Jacinta M Ortega,1 Joanne L Hart,1 Thomas Klein,2 Simon Potocnik11School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia; 2Department of Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma, Biberach, GermanyCorrespondence: Owen L WoodmanBaker...
Saved in:
Main Authors: | Woodman OL, Ortega JM, Hart JL, Klein T, Potocnik S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/a59d569264924aebbc71eba60415f80c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
by: Taras S. Panevin, et al.
Published: (2020) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012) -
Disfunción endotelial como alteración primaria en las patologías vasculares
by: Irribarra P,Verónica, et al.
Published: (2000) -
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
by: Han E, et al.
Published: (2020) -
Endothelium journal of endothelial cell research.
Published: (1993)